Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

0.3872
BATS BZX Real-Time Price
As of 9:31am ET
 -0.0126 / -3.15%
Today’s Change
0.36
Today|||52-Week Range
1.39
-66.04%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +545.66% increase from the last price of 0.39.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.11
Sales
$0.00
Reporting Date
Nov 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 57.69%
 
 
 
 
 
 
Growthannually -31.91%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.